First batch of Covid-19 vaccine out within 2 weeks: Russian Health Minister

While covering Russians' needs is a priority, the vaccine could also be exported abroad, the health minister said

covid-19, vaccine, coronavirus
On Tuesday, the Russian Health Ministry registered the first coronavirus vaccine in the world
ANI Asia
1 min read Last Updated : Aug 12 2020 | 2:45 PM IST

The first batch of the Russian vaccine against Covid-19 is expected to be released within two weeks, Health Minister Mikhail Murashko said on Wednesday.

On Tuesday, the Russian Health Ministry registered the first coronavirus vaccine in the world. The vaccine, named Sputnik V, was developed jointly by the Gamaleya Research Institute and the Russian Defense Ministry.

ALSO READ: WHO in contact with Russia on new Covid-19 vaccine: Spokesman

"Within two weeks, the first batch of the vaccine will be released," Murashko said at a press conference.

"The vaccination will be voluntary anyway. Some of those doctors who already have immunity against the coronavirus, there are around 20 per cent, ... think they do not need vaccination, it will be up to them to decide," Murashko assured.

ALSO READ: Russia registers first Covid vaccine, hopes to begin mass inoculation soon

While covering Russians' needs is a priority, the vaccine could also be exported abroad, the health minister added.

"The vaccine certainly has some export potential, and we will certainly offer it [to foreign countries], but the domestic market needs are our priority," Murashko said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineRussia

Next Story